Compumedics Limited specialising in sleep, brain, and ultrasonic blood flow monitoring, has signed two new 4-year distribution agreements with long-standing partners in China.
The agreements, valued at A$24.4 million in total, strengthen Compumedics’ presence across key regions in Asia. The first, a A$20 million agreement, extends the Company’s established partnership with its long-term Northern China distributor focused on sleep diagnostics. The second, valued at A$4.4 million, renews a long-standing relationship with an Eastern China distributor focused on sleep and neurology. Both agreements include a minimum +10% per annum growth commitment, providing a clear trajectory for expanding sales in one of Compumedics’ most strategically important markets where Compumedics has had a significant involvement for over 20 years.
Executive Chairman and CEO Dr David Burton commented: “These agreements demonstrate the strong momentum behind the step-change underway at Compumedics, a shift focused on profitable growth, recurring revenue, and geographic diversification. China remains a key engine for expansion, and these multi-year contracts secure predictable, growing revenues in one of our most strategically important markets. Coupled with increasing traction in the US and across our connected platforms, we are now scaling a more focused, cash-generative global business.”
